Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Alzheimer's Disease

Free Subscription 06.04.2026 1 Acta Neuropathol 9 Alzheimers Dement 3 BMC Neurol 1 Brain 4 Curr Alzheimer Res 1 Dement Geriatr Cogn Disord 1 Exp Gerontol 8 J Alzheimers Dis 1 J Biol Chem 2 J Neurochem 1 J Neuropsychol 2 JAMA 2 Nat Med 1 Neurobiol Dis 2 Neurochem Res 1 Neurology 1 Neurosci Lett 1 Neuroscience 2 PLoS One 2 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. THORNS V, Mallory M, Hansen L, Masliah E, et al
   Correction: Alterations in glutamate receptor 2/3 subunits and amyloid precursor protein expression during the course of Alzheimer's disease and Lewy body variant.
   Acta Neuropathol. 2026;151:33.
   PubMed        
   
   

   
   Alzheimers Dement

2. GONZALEZ AD, Ghaseminejad-Bandpey A, Seshadri S, Etemadmoghadam S, et al
   Modeling small vessel disease burden and vascular dementia likelihood from NACC data.
   Alzheimers Dement. 2026;22:e71325.
   PubMed         Abstract available
   
   
3. HE T, Betensky RA, Osorio RS, Swinnerton K, et al
   Neutrophil inflammation metrics are associated with the risk of future dementia in large data from NYU Langone Hospitals and the Veterans Health Administration.
   Alzheimers Dement. 2026;22:e71335.
   PubMed         Abstract available
   
   
4. SHIMIZU A, Iwabuchi Y, Bun S, Watanabe M, et al
   Florzolotau (18F) retention is linked to neuropsychological performance in tauopathy.
   Alzheimers Dement. 2026;22:e71319.
   PubMed         Abstract available
   
   
5. YANG R, Wang J, Dove A, Sakakibara S, et al
   Association of the Planetary Health Diet with dementia risk and brain pathology.
   Alzheimers Dement. 2026;22:e71327.
   PubMed         Abstract available
   
   
6. MACHEDA T, Hawkins MR, Johnson CE, Lapid MG, et al
   Glial cytokine modulation improves sleep and circadian disruption in female SAA knock-in mice of Alzheimer's-related pathology.
   Alzheimers Dement. 2026;22:e71314.
   PubMed         Abstract available
   
   
7. LI T, Liu M, Zhang P, Li S, et al
   Associations between sleep disturbance and cerebrospinal fluid Abeta, and shared proteomic signatures in Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71316.
   PubMed         Abstract available
   
   
8. NAM Y, DeRosa BA, Ramirez AM, Ayele BA, et al
   Disrupted lipid homeostasis as a pathogenic mechanism in ABCA7-associated Alzheimer's disease risk.
   Alzheimers Dement. 2026;22:e71312.
   PubMed         Abstract available
   
   
9. DORFSMAN D, Prough MB, Gulyayev A, Caywood LJ, et al
   WDR12 and HIVEP3 are contributors to cognitive preservation in Amish SuperAgers.
   Alzheimers Dement. 2026;22:e71293.
   PubMed         Abstract available
   
   
10. ZENG X, Li Y, Hua L, Lu R, et al
    Spatially and temporally progressive hypoperfusion in Alzheimer's disease revealed by normative modeling.
    Alzheimers Dement. 2026;22:e71203.
    PubMed         Abstract available
    
    

    
    BMC Neurol

11. FAEED M, Hosseini H, Abdollahi A, Aziz M, et al
    Plasma miRNAs associated with cognitive impairment and brain hypometabolism in individuals with mild cognitive impairment.
    BMC Neurol. 2026;26:200.
    PubMed         Abstract available
    
    
12. LIU T, Huang Z, Qin H
    Astrocyte autophagy-pyroptosis crosstalk in Alzheimer's: insights from knowledge graphs.
    BMC Neurol. 2026 Mar 28. doi: 10.1186/s12883-026-04793.
    PubMed        
    
    
13. HAMAGUCHI T, Hamano T, Senoh T, Kawasaki Y, et al
    Early onset Alzheimer's disease with V180I variant of prion protein gene and a family history of dementia: a case report.
    BMC Neurol. 2026 Apr 2. doi: 10.1186/s12883-026-04865.
    PubMed        
    
    

    
    Brain

14. BARRANTES FJ
    Synapse-associated neuropathological markers in Alzheimer disease.
    Brain. 2026 Mar 30:awag117. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Curr Alzheimer Res

15. BAZZARI FH, Bazzari AH
    Amyloid-Beta Immunotherapies for Alzheimer's Disease: Current Progress.
    Curr Alzheimer Res. 2026 Mar 30. doi: 10.2174/0115672050468315260226041235.
    PubMed         Abstract available
    
    
16. MISHRA R, Gupta JK
    Decoding microRNA-Protein Interaction Networks in Alzheimer's Disease: Molecular Mechanisms and Clinical Implications.
    Curr Alzheimer Res. 2026 Mar 30. doi: 10.2174/0115672050451919260313061818.
    PubMed         Abstract available
    
    
17. KHAN AH, Ubaid B, Perry G
    Reconciling Divergent Perspectives: A Deep Analysis of Sex Differences in Alzheimer's Disease Mortality Data.
    Curr Alzheimer Res. 2026 Mar 31. doi: 10.2174/0115672050450797260211050217.
    PubMed        
    
    
18. MEHRABADI S, Samarghandian S
    Glymphatic System Dysfunction in Alzheimer's Disease: Insights into its Mechanisms, Diagnostic Imaging, and Therapeutic Perspectives: A Systematic Review.
    Curr Alzheimer Res. 2026 Mar 27. doi: 10.2174/0115672050428286260225033532.
    PubMed         Abstract available
    
    

    
    Dement Geriatr Cogn Disord

19. KIM D, Lee WJ, Jeon DH, Lee H, et al
    Correlational Validity and Biomarker Associations of the Korean Computerized Cognitive Function Test (CFT-S) Relative to the Seoul Neuropsychological Screening Battery in MCI and Alzheimer's Disease.
    Dement Geriatr Cogn Disord. 2026 Mar 30:1-21. doi: 10.1159/000551744.
    PubMed         Abstract available
    
    

    
    Exp Gerontol

20. VANGILDER JL, Hooyman A, Hakhu S, Schilling KG, et al
    Using diffusion MRI to relate hippocampal subfield microstructure to delayed verbal memory in cognitively intact individuals at genetic risk for developing Alzheimer's disease.
    Exp Gerontol. 2026 Mar 27:113112. doi: 10.1016/j.exger.2026.113112.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

21. CAMARGO A, Mauro GD, Wang Z
    Cross entropy gradient analysis for Alzheimer's disease assessment.
    J Alzheimers Dis. 2026 Mar 30:13872877261431317. doi: 10.1177/13872877261431317.
    PubMed         Abstract available
    
    
22. DIAZ CARO D, Rodriguez S, Uhlmann WR, Goldman JS, et al
    Exploring immediate responses to APOEepsilon4/epsilon4 genotype and Alzheimer's disease risk disclosure in Latinos.
    J Alzheimers Dis. 2026 Mar 30:13872877261435633. doi: 10.1177/13872877261435633.
    PubMed         Abstract available
    
    
23. GATTO RG, Youssef H
    Influence of sex on tau distribution across Braak stages in the Alzheimer's disease spectrum.
    J Alzheimers Dis. 2026 Mar 30:13872877261433219. doi: 10.1177/13872877261433219.
    PubMed         Abstract available
    
    
24. KONG X, Han R, Fan X, Wei K, et al
    Acupuncture as an adjunct therapy for mild Alzheimer's disease: A randomized clinical trial.
    J Alzheimers Dis. 2026 Mar 30:13872877261435880. doi: 10.1177/13872877261435880.
    PubMed         Abstract available
    
    
25. YE X, Hu K, Liu R
    Aerobic exercise intervention in Alzheimer's disease: Proteomic insights into peripheral T cell-mediated immune pathways.
    J Alzheimers Dis. 2026 Mar 30:13872877261436840. doi: 10.1177/13872877261436840.
    PubMed         Abstract available
    
    
26. SHAH J, Karanja W, Merali Z, Ali SK, et al
    Trends and projections for Alzheimer's disease and other dementias in Kenya: Analysis of the global burden of disease data 1990-2021 in relation to Africa and the world.
    J Alzheimers Dis. 2026 Mar 30:13872877261434256. doi: 10.1177/13872877261434256.
    PubMed         Abstract available
    
    
27. QIN J, Xu X, Zou Y
    Herpes zoster, antiviral therapy, and Alzheimer's disease: Turning association into an actionable prevention pathway.
    J Alzheimers Dis. 2026 Apr 3:13872877261438524. doi: 10.1177/13872877261438524.
    PubMed         Abstract available
    
    
28. VIJVERBERG EGB, Scharre DW, Woodward M, Catalano S, et al
    Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease.
    J Alzheimers Dis. 2026 Apr 3:13872877261437145. doi: 10.1177/13872877261437145.
    PubMed         Abstract available
    
    

    
    J Biol Chem

29. MON F, Straub JE
    Structural and mechanistic characterization of heparin interactions with tau fibrils.
    J Biol Chem. 2026;302:111153.
    PubMed         Abstract available
    
    

    
    J Neurochem

30. OLIVERA E, Saez A, Castro M, Garaventa P, et al
    A Decline in Metabotropic Glutamate mGlu3 Receptor Levels Is Associated With Amyloid Plaques in Alzheimer's Disease and Is Detectable in Serum During Mild Cognitive Impairment.
    J Neurochem. 2026;170:e70417.
    PubMed         Abstract available
    
    
31. MACIEL EMA, Silva NC, Santos LGP, Ribeiro FM, et al
    Advances in hiPSC-Derived Brain Organoids as a Model to Study Neuroinflammation in Alzheimer's Disease.
    J Neurochem. 2026;170:e70416.
    PubMed         Abstract available
    
    

    
    J Neuropsychol

32. LOUKOLA HR, Karkkainen M, Selander T, Honkalampi K, et al
    Associations between apathy and global cognition in a 5-year follow-up of individuals with Alzheimer's disease.
    J Neuropsychol. 2026 Mar 30. doi: 10.1111/jnp.70044.
    PubMed         Abstract available
    
    

    
    JAMA

33. DEVANAND DP, Wei R, Qian M
    Treatment of Early Symptomatic Alzheimer Disease With Valacyclovir-Reply.
    JAMA. 2026 Apr 2. doi: 10.1001/jama.2026.1105.
    PubMed        
    
    
34. KOSAKA M, Kami M
    Treatment of Early Symptomatic Alzheimer Disease With Valacyclovir.
    JAMA. 2026 Apr 2. doi: 10.1001/jama.2026.1102.
    PubMed        
    
    

    
    Nat Med

35. O'LEARY K
    GLP-1 receptor agonist fails to halt Alzheimer's disease.
    Nat Med. 2026 Mar 31. doi: 10.1038/d41591-026-00018.
    PubMed        
    
    
36. CUMMINGS JL, Agadjanyan MG, Barry M, Corey L, et al
    Target product profiles for treatments to delay or prevent symptomatic Alzheimer's disease.
    Nat Med. 2026 Apr 3. doi: 10.1038/s41591-026-04305.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

37. SIMPSON D, Morrone CD, Wear D, Khani A, et al
    Neurovascular large artery dilatation increases the risk for Alzheimer's disease pathology.
    Neurobiol Dis. 2026 Mar 27:107368. doi: 10.1016/j.nbd.2026.107368.
    PubMed         Abstract available
    
    

    
    Neurochem Res

38. TRIPATHI P, Shah J
    Vitamin D(3) Attenuates Alzheimer's Disease-Like Pathology via Remodeling Amyloid Protein Production and Clearance Pathway in Wistar Rats.
    Neurochem Res. 2026;51:128.
    PubMed         Abstract available
    
    
39. LIU S, Yan J, Dong J
    Curcumin and Glycyrrhiza glabra Synergistically Attenuate Alzheimer's Pathology via TLR4/NF-kappaB-Mediated Anti-inflammatory and Redox Modulation in a D-Gal/Sodium Nitrite-Induced Mouse Model.
    Neurochem Res. 2026;51:129.
    PubMed         Abstract available
    
    

    
    Neurology

40. BUKHBINDER AS, Ling Y, Jhin L, He E, et al
    Risk of Alzheimer Dementia After High-Dose vs Standard-Dose Influenza Vaccination.
    Neurology. 2026;106:e214782.
    PubMed         Abstract available
    
    

    
    Neurosci Lett

41. NASIRI H, Mohammadtaheri B, Khosravi F, Ghadiminia N, et al
    Default mode network connectivity is associated with executive and language performance in mild cognitive impairment.
    Neurosci Lett. 2026;876:138545.
    PubMed         Abstract available
    
    

    
    Neuroscience

42. WANG S, Wei Y, Li Y, Qing H, et al
    Effects of different exercise modalities on four major neurodegenerative diseases and their molecular mechanisms.
    Neuroscience. 2026;601:121-135.
    PubMed         Abstract available
    
    

    
    PLoS One

43. GARCIA OLIVERA F
    Proteome-based investigation of O-GlcNAcylation in a C. elegans model of ageing and Alzheimer's disease: Functional support for earlier hypothesis-generating findings.
    PLoS One. 2026;21:e0344865.
    PubMed         Abstract available
    
    
44. XIONG X, Wang X, Zhu C, He J, et al
    Disease progression modeling of Alzheimer's disease based on variational probability principal component analysis.
    PLoS One. 2026;21:e0342549.
    PubMed         Abstract available
    
    

    
    Science

45. REINEKE LC, Zhu PJ, Dalwadi U, Dooling SW, et al
    Harnessing viral strategies to reverse cognitive dysfunction through the integrated stress response.
    Science. 2026;392:eaea8782.
    PubMed         Abstract available
    
    
46. SMITH JE
    Scientists brace for expansion of Alzheimer's blood tests.
    Science. 2026;392:14-15.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum